Showing results (271-280 of 3,079) with videos related to
Sort By:
Pageof 308
Drug Safety|October 17, 2002
Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a review of 10 years' experienceRachel Forman, Gideon Koren, Neil H ShearDrug Safety|September 21, 2002
Selective cyclo-oxygenase-2 inhibitors and myocardial infarction: how strong is the link?Laurence G Howes, Henry KrumDrug Safety|December 24, 2002
Cytochrome P450 drug interactions within the HMG-CoA reductase inhibitor class: are they clinically relevant?Jennifer Martin, Henry KrumDrug Safety|November 21, 2000
Thrombolytics: drug interactions of clinical significanceS Harder, U KlinkhardtDrug Safety|June 20, 2002
A data mining approach for signal detection and analysisAndrew Bate, Marie Lindquist, I Ralph Edwards, et al.Drug Safety|June 20, 2002
Signal selection and follow-up in pharmacovigilanceRonald H B Meyboom, Marie Lindquist, Antoine C G Egberts, et al.Drug Safety|June 20, 2002
Causal association in pharmacovigilance and pharmacoepidemiology: thoughts on the application of the Austin Bradford-Hill criteriaSaad A W Shakir, Deborah LaytonDrug Safety|July 3, 2002
A preliminary benefit-risk assessment of lamivudine for the treatment of chronic hepatitis B virus infectionFabien ZoulimDrug Safety|July 13, 2002
Safety and tolerability of eprosartan in combination with hydrochlorothiazideMichael Böhm, Alisia SachseDrug Safety|July 13, 2002
Approaches toward repeated supratherapeutic doses of paracetamol in children: a survey of medical directors of poison centres in North America and EuropeEran Kozer, Michael McGuiganPageof 308